Pure Biologics

Pure Biologics is the first entity in Poland dedicated to developing novel, non-generic or biosimilar drugs based on antibodies and therapeutic aptamers. Pure Biologics' therapeutic portfolio includes new immuno-oncology therapies and non-systemic treatments for autoimmune, neurodegenerative, and rare diseases. In total, there are over a dozen projects, including five key projects where we use antibody and aptamer technologies to develop molecules with therapeutic potential.